References
- Hultcrantz R, Glaumann H, Lindberg G, et al. Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum amino-transferases. Scand J Gastroenterol 1986: 21(1): 109–13
- Van Ness MM, Diehl AM. Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Ann Intern Med 1989: 111(6): 473–8
- Maddrey WC. Chronic hepatitis. In: Zakim D, Boyer TD, eds. Hepatology: a textbook of liver disease. 2d ed, vol 2. Philadelphia: WB Saunders, 1990: 1025–60
- Perrillo RP, Schiff ER, Davis GL, et al. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic heparins B. N Engl J Med 1990: 323(5): 295–301
- Jacyna MR, Brooks MG, Loke RH, et al. Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis. BMJ 1989: 298(6666): 80–2
- Davis GL, Balart LA, Schiff ER, et al. Treatment of chronic heparins C with recombinant interferon alfa: a multicenter randomized, controlled trial. N Engl J Med 1989 321(22): 1501–6
- Di Bisceglie AM, Martin P, Kassianids C, et al. Recombinant interferon alfa therapy for chronic hepatitis C: a randomized, double-blind, placebo-controlled trial. N Engl J Med 1989 321(22): 1506–10
- Marcellin P, Boyer N, Giostra E, et al. Recombinant human α-interferon in patients with chronic non-A non-B heparins: a multicenter randomized controlled trial from France. Hepatology 1991: 13(3): 393–7
- Di Bisceglie AM, Hoofnagle JH. Therapy of chronic hepatitis C with α-interferon. The answer? Or more questions? (Editorial) Hepatology 1991: 13(3): 601–3